Clinical ethics
Lives in a chiaroscuro. Should we suspend the puberty of children with gender identity disorder?
Correspondence to:
Dr S Giordano, CSEP/IMLAB, and the Manchester Institute of Science, Ethics and Innovation, The University of Manchester, Williamson Building, The School of Law, Oxford Road, Manchester M13 9PL, UK; simona.giordano{at}manchester.ac.uk
Transgender children who are not treated for their condition are at high risk of violence and suicide. As a matter of survival, many are willing to take whatever help is available, even if this is offered by illegal sources, and this often traps them into the juvenile criminal system and exposes them to various threats. Endocrinology offers a revolutionary instrument to help children/adolescents with gender identity disorder: suspension of puberty. Suspension of puberty raises many ethical issues, and experts dissent as to when treatment should be commenced and how children should be followed up. This paper argues that suspension of puberty is not only not unethical: if it is likely to improve the childs quality of life and even save his or her life, then it is indeed unethical to defer treatment.
This article has been cited by other articles:
-
Mul, D, Hughes, I A
(2008). The use of GnRH agonists in precocious puberty. Eur J Endocrinol
159: S3-S8
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
